Announcements Trials

Browse Landscape

Phase

Status

Completed 5 Terminated 4 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Melanoma 4 Thyroid Carcinoma, Anaplastic 3 Neoplasms 3 Glioma 3 Colorectal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Thyroid Neoplasms 1 Spinocerebellar Degenerations 1 Solid Tumor 1 Skin Neoplasms 1 Sexual Dysfunction, Physiological 1 Refractory Differentiated Thyroid Gland Carcinoma 1 Recurrence 1 Rare Malignant Neoplasm 1 Oligodendroglioma 1 Neurofibromatosis 1 1 Neurofibroma, Plexiform 1 Neurocytoma 1 Neuroblastoma 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Lung Neoplasms 1 Locally Advanced Thyroid Gland Carcinoma 1 Histiocytosis, Langerhans-Cell 1 Hematologic Neoplasms 1 Glioblastoma 1 Ganglioneuroma 1 Ganglioglioma 1 Eunuchism 1

Interventions

pembrolizumab 49 Specimen Handling 29 Magnetic Resonance Spectroscopy 25 Biopsy 25 Radiosurgery 17 Gemcitabine 17 Nivolumab 16 Cyclophosphamide 14 Cisplatin 14 Paclitaxel 13 Carboplatin 13 Bevacizumab 13 Leucovorin 11 Irinotecan 11 Fluorouracil 11 Drug Therapy 11 Taxes 10 Radiotherapy 10 Oxaliplatin 10 Capecitabine 10 trastuzumab deruxtecan 9 fludarabine 9 cemiplimab 8 Doxorubicin 8 Cetuximab 8 abemaciclib 7 Trastuzumab 7 Pemetrexed 7 Fulvestrant 7 Docetaxel 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Neoplasm Metastasis × dabrafenib × Clear all

NCT04116541 2026-04-24

MegaMOST

Centre Leon Berard

Phase 2 Recruiting

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡